PharmNovo
Relieving chronic pain
- CEO: Per von Mentzer
- First investment year: 2020
- Fund: South
- Business sector: Life Science
PharmNovo is developing a drug for the relief of nerve pain based on non-addictive opioids.
Relieving chronic pain
PharmNovo is developing a drug for the relief of nerve pain based on non-addictive opioids.